onc Videos

Videos

Videos

Predicting Long-Term Effects Among Patients Treated for Early-Stage Hodgkin Lymphoma

09/07/2023

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Evens, DO, MBA, MSc, discusses the management and prediction of long-term effects among patients treated for early-stage Hodgkin lymphoma.

At the 2023 Great Debates &...

09/07/2023

Oncology

Videos

Initiating Improvements in Access and Diversity in Clinical Trials for Patients With Multiple Myeloma

09/07/2023

Monique Hartley-Brown , MD, MMSc;

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Monique Hartley-Brown, MD, MMSc, discusses initiatives to improve diversity and accessibility in clinical trials for patients with MM.

At the 2023 Great Debates &...

09/07/2023

Oncology

Videos

Selecting Optimal Treatments for Patients With Relapsed Multiple Myeloma

09/06/2023

Andrew Yee , MD;

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Yee, MD, discusses treatment options for patients with relapsed MM, including anti-CD38 antibodies, cyclophosphamide-based combinations, and BCL-2 inhibitors.

At the 2023 Great Debates &...

09/06/2023

Oncology

Videos

Pirtobrutinib Demonstrates Durable Efficacy and Safety Among Patients With Covalent BTK Inhibitor Pretreated R/R MCL

09/05/2023

Kami J. Maddocks , MD;

Kami J. Maddocks, MD, analyzes the updated results of the BRUIN trial on the efficacy and safety of pirtobrutinib among patients with high-risk heavily pretreated R/R mantle cell lymphoma with prior covalent BTK inhibitor therapy.

Kami J. Maddocks, MD, analyzes...

09/05/2023

Oncology

Videos

Exploring Mechanisms and Approaches for Graft-Versus-Host Disease Prophylaxis

09/05/2023

Ernst Holler , MD;

Ernst Holler, MD, provides insights and analyses regarding the latest mechanisms and approaches for graft-versus-host disease prophylaxis, explaining the latest evolution of T-cell interaction methods.

Ernst Holler, MD, provides...

09/05/2023

Oncology

Videos

Analyzing Risk Factors for Acute and Chronic Graft-Versus-Host Disease

09/05/2023

Ernst Holler , MD;

Ernst Holler, MD, provides expert insights into the latest data on risk factors for the development of acute and chronic graft-versus-host disease.

Ernst Holler, MD, provides...

09/05/2023

Oncology

Videos

Antibody Drug Conjugates for the Frontline Treatment of Patients With Advanced-Stage Hodgkin Lymphoma

09/05/2023

Andrew M. Evens , DO, MSc;

Andrew Evens, DO, MBA, MSc, analyzes the first-line treatment landscape for patients with advanced-stage Hodgkin lymphoma through the integration of antibody drug conjugates, at the 2023 Great Debates & Updates in Hematologic Malignancies...

Andrew Evens, DO, MBA, MSc,...

09/05/2023

Oncology

Videos

Promising Outcomes of FGFR1 Inhibitor Pemigatinib for Myeloid Lymphoid Neoplasms

08/28/2023

Daniel DeAngelo , MD, PhD;

Daniel DeAngelo, MD, PhD, presents data on the promising outcomes of pemigatinib, an FGFR1 inhibitor, among patients with myeloid lymphoid neoplasms, at the 2023 Great Debates & Updates in Hematologic Malignancies meeting.

Daniel DeAngelo, MD, PhD,...

08/28/2023

Oncology

Shinichi Nishina, MD, Kurashiki Central Hospital

Videos

RAS Status in ctDNA After Chemotherapy Among Patients With RAS-Mutant Colorectal Cancer

08/28/2023

Shinichi Nishina , MD;

At the 2023 World Congress on Gastrointestinal Cancers, Shinichi Nishina, MD, reported data on that RAS status in ctDNA of patients with RAS-mutant metastatic colorectal cancer who responded to first- or second-line chemotherapy.

At the 2023 World Congress on...

08/28/2023

Oncology

Videos

Increasing Incidence of Early-Onset Colorectal Cancer

08/28/2023

Irit Ben-Aharon , MD, PhD;

At the 2023 World Congress on Gastrointestinal Cancers, Irit Ben-Aharon, MD, PhD discussed how the incidence of early-onset colorectal cancer has risen over the past 2 decades.

At the 2023 World Congress on...

08/28/2023

Oncology

Recent News

News

FDA Grants Approval to Revumenib for Patients With R/R Acute Leukemia With KMT2A Translocation

11/17/2024

On November 15, 2024, the FDA approved menin inhibitor revumenib for adult and pediatric patients 1 year and older with relapsed/refractory acute leukemia with KMT2A translocation.

On November 15, 2024, the FDA...

11/17/2024

Oncology

News

Intraoperative Radiation Therapy May Improve Survival For Certain Patients With Recurrent Cervical or Endometrial Cancer

11/14/2024

Allison Casey ;

According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.

According to a retrospective...

11/14/2024

Oncology

News

Amrubicin Plus Irinotecan Demonstrates Promising Efficacy, Safety for Chemotherapy-Naïve Patients With Extensive-Disease Small Cell Lung Cancer

11/14/2024

Stephanie Holland ;

According to results from the phase 2 LC 08-01 trial, amrubicin plus irinotecan demonstrated promising efficacy and safety among chemotherapy-naïve patients with extensive-disease small cell lung cancer.

According to results from the...

11/14/2024

Oncology

News

Addition of Bempegaldesleukin to Nivolumab Does Not Benefit Cisplatin-Ineligible Patients With First-Line Advanced Urothelial Carcinoma

11/13/2024

Stephanie Holland ;

Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma.

Results from the phase 2...

11/13/2024

Oncology

News

Mirdametinib for Adult and Pediatric Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

11/12/2024

Allison Casey ;

According to a phase 2b trial, mirdametinib demonstrated significant confirmed objective response rates with deep and durable reductions of volume of target plexiform neurofibromas and clinically meaningful improvements to health-related...

According to a phase 2b trial,...

11/12/2024

Oncology

News

Epirubicin Plus Cyclophosphamide and Docetaxel Reduces Long-Term Risk of Recurrence for Patients With TOP2A Normal Early Breast Cancer

11/12/2024

Stephanie Holland ;

According to final results from the DBCG 07-READ trial, the addition of epirubicin to cyclophosphamide and docetaxel reduced long-term risk of breast cancer recurrence among patients with TOP2A normal early breast cancer.

According to final results from...

11/12/2024

Oncology

News

Pembrolizumab Plus Chemotherapy For Patients With High-Risk Endometrial Cancer

11/11/2024

Allison Casey ;

According to results from a phase 3 trial, pembrolizumab plus chemotherapy did not improve DFS among patients with high-risk endometrial cancer. However, there may be a benefit among patients with mismatch report-deficient disease.

According to results from a...

11/11/2024

Oncology

FDA Approval

FDA Grants Approval to Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia

11/08/2024

On November 8, 2024, the FDA approved CD19-directed genetically modified autologous T cell immunotherapy obecabtagene autoleucel for the treatment of patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

On November 8, 2024, the FDA...

11/08/2024

Oncology

News

Naporafenib in Combination With Rineterkib or Tremetinib for KRAS- or BRAF-Mutant Non-Small Cell Lung Cancer

11/07/2024

Allison Casey ;

While naporafenib plus rineterkib and naporafenib plus trametinib both had acceptable safety profiles, antitumor activity was limited among patients with KRAS-/BRAF-mutant non-small cell lung cancer.

While naporafenib plus...

11/07/2024

Oncology

News

Addition of Concurrent Thoracic Radiotherapy to First-Line TKI Therapy Improves Survival for Patients With EGFR-Mutated Non-Small Cell Lung Cancer

11/06/2024

Stephanie Holland ;

According to results from a phase 3 trial, the addition of concurrent thoracic radiotherapy to first-line icotinib improved survival among patients with EGFR-mutated oligo-organ metastatic non-small cell lung cancer.

According to results from a...

11/06/2024

Oncology